Invesclinic US McAllen Oncology — McAllen, Texas

Invesclinic US McAllen Oncology is a clinical research site located in McAllen, Texas, United States 78577.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Invesclinic US McAllen Oncology has participated in 1 clinical trials.

Therapeutic areas: Adult Solid Tumor.

Sponsors: Mitra RxDx, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in McAllen

Browse all research sites in Texas · View every site in McAllen

• Doctors Hospital at Renaissance
• McAllen Medical Heart Hospital
• University of Texas Medical Branch Cancer Stop McAllen Clinic
• Rio Grande Regional Hospital Main Campus
• Rio Grande Regional Hospital
• Doctor's Hospital at Renaissance
• Valley Retina Institute
• Research Site
• Futuro Clinical Trials
• Valley Retina Institute,PA
• Texas Oncology McAllen
• Biopharma Informatic

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Invesclinic US McAllen Oncology?

Invesclinic US McAllen Oncology has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Invesclinic US McAllen Oncology conducted?

Invesclinic US McAllen Oncology has 1 clinical trials on record. Their work covers Adult Solid Tumor.

Is Invesclinic US McAllen Oncology accredited by Crixeo Clinical Trials?

Invesclinic US McAllen Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Invesclinic US McAllen Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.